UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000000714
Receipt number R000000849
Scientific Title A feasibility test on a postoperative Docetaxel plus TS-1 therapy for the patients with stage IIIA or stage IIIB gastric cancer (OGSG-0604)
Date of disclosure of the study information 2007/05/17
Last modified on 2022/11/06 14:37:43

No. Disposal Last modified on Item of update
1 Insert 2007/05/10 14:19:18
2 Update 2007/05/17 14:16:01 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Address
Address
TEL
3 Update 2007/05/17 14:48:01 Organization
4 Update 2007/05/17 15:49:52 Organization
Organization
5 Update 2007/08/23 14:01:29 Recruitment status
6 Update 2007/08/23 14:25:50 Recruitment status
7 Update 2008/11/06 17:15:59 Recruitment status
8 Update 2009/04/30 18:21:48 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2012/06/24 23:18:35 Public title
Public title
Acronym
Acronym
10 Update 2012/06/24 23:28:39 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Address1
Tel1
Email1
11 Update 2012/06/24 23:33:25 Last name of contact person
12 Update 2012/06/24 23:37:46 Division name
Name of person sending information
13 Update 2012/06/24 23:51:02 Organization
Organization
14 Update 2017/02/12 23:50:29 Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
URL releasing protocol
Publication of results
15 Update 2018/07/16 17:57:17 URL releasing protocol
URL related to results and publications
16 Update 2022/11/06 14:18:22 Date of IRB
17 Update 2022/11/06 14:37:43 URL releasing protocol
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures